Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines
- PMID: 23435233
- PMCID: PMC3640511
- DOI: 10.3390/v5020470
Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines
Abstract
Virus infections are a major global public health concern, and only via substantial knowledge of virus pathogenesis and antiviral immune responses can we develop and improve medical treatments, and preventive and therapeutic vaccines. Innate immunity and the shaping of efficient early immune responses are essential for control of viral infections. In order to trigger an efficient antiviral defense, the host senses the invading microbe via pattern recognition receptors (PRRs), recognizing distinct conserved pathogen-associated molecular patterns (PAMPs). The innate sensing of the invading virus results in intracellular signal transduction and subsequent production of interferons (IFNs) and proinflammatory cytokines. Cytokines, including IFNs and chemokines, are vital molecules of antiviral defense regulating cell activation, differentiation of cells, and, not least, exerting direct antiviral effects. Cytokines shape and modulate the immune response and IFNs are principle antiviral mediators initiating antiviral response through induction of antiviral proteins. In the present review, I describe and discuss the current knowledge on early virus-host interactions, focusing on early recognition of virus infection and the resulting expression of type I and type III IFNs, proinflammatory cytokines, and intracellular antiviral mediators. In addition, the review elucidates how targeted stimulation of innate sensors, such as toll-like receptors (TLRs) and intracellular RNA and DNA sensors, may be used therapeutically. Moreover, I present and discuss data showing how current antimicrobial therapies, including antibiotics and antiviral medication, may interfere with, or improve, immune response.
Figures
Similar articles
-
Cytosolic DNA-sensing immune response and viral infection.Microbiol Immunol. 2019 Feb;63(2):51-64. doi: 10.1111/1348-0421.12669. Epub 2019 Feb 26. Microbiol Immunol. 2019. PMID: 30677166 Free PMC article. Review.
-
Activation of host pattern recognition receptors by viruses.Curr Opin Microbiol. 2010 Aug;13(4):503-7. doi: 10.1016/j.mib.2010.05.007. Epub 2010 Jun 9. Curr Opin Microbiol. 2010. PMID: 20538506 Review.
-
Recognition of bacterial infection by innate immune sensors.Crit Rev Microbiol. 2013 Aug;39(3):229-46. doi: 10.3109/1040841X.2012.706249. Epub 2012 Aug 6. Crit Rev Microbiol. 2013. PMID: 22866947 Review.
-
Recognition of viral nucleic acids in innate immunity.Rev Med Virol. 2010 Jan;20(1):4-22. doi: 10.1002/rmv.633. Rev Med Virol. 2010. PMID: 20041442 Review.
-
[Signal transduction of innate immunity to virus infection].Bing Du Xue Bao. 2012 May;28(3):303-10. Bing Du Xue Bao. 2012. PMID: 22764536 Review. Chinese.
Cited by
-
Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.J Virol. 2017 May 12;91(11):e00179-17. doi: 10.1128/JVI.00179-17. Print 2017 Jun 1. J Virol. 2017. PMID: 28331091 Free PMC article.
-
Humanized-VHH transbodies that inhibit HCV protease and replication.Viruses. 2015 Apr 20;7(4):2030-56. doi: 10.3390/v7042030. Viruses. 2015. PMID: 25903832 Free PMC article.
-
Increase in liver γδ T cells with concurrent augmentation of IFN-β production during the early stages of a mouse model of acute experimental hepatitis B virus infection.Exp Ther Med. 2020 Jan;19(1):67-78. doi: 10.3892/etm.2019.8197. Epub 2019 Nov 13. Exp Ther Med. 2020. PMID: 31853274 Free PMC article.
-
Engineering complexity in human tissue models of cancer.Adv Drug Deliv Rev. 2022 May;184:114181. doi: 10.1016/j.addr.2022.114181. Epub 2022 Mar 9. Adv Drug Deliv Rev. 2022. PMID: 35278521 Free PMC article. Review.
-
HIV: Slipping under the radar.Nature. 2013 Nov 21;503(7476):352-3. doi: 10.1038/nature12707. Epub 2013 Nov 6. Nature. 2013. PMID: 24196714 No abstract available.
References
-
- Kim H.M., Park B.S., Kim J.I., Kim S.E., Lee J., Oh S.C., Enkhbayar P., Matsushima N., Lee H., Yoo O.J., et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 2007;130:906–917. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical